Taken together, these results suggest that the activation of MEK/ERK1/2 signaling plays a crucial role in COX-2 expression and prostaglandin E2 release in synovial fibroblasts that is important in the pathogenesis of synovitis in patients with RA. This evidence concerns the gene MAPK3 and rheumatoid arthritis.